Information  X 
Enter a valid email address

Company Name matching 'Crown Bioscience'

Date
Time Source
Company
Announcement
12 Jun 2019 1:00 pm GNW     Crown Bioscience Crown Bioscience Announces Four New Preclinical NASH Models In Development
09 May 2019 1:30 pm GNW     Crown Bioscience Crown Bioscience Announces San Diego, CA Site Expansion
27 Mar 2019 12:00 pm GNW     Crown Bioscience CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services
21 Mar 2019 12:30 pm GNW     Crown Bioscience Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 2019
12 Mar 2019 12:30 pm GNW     Crown Bioscience Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model
05 Mar 2019 8:35 pm GNW     Crown Bioscience Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model
18 Dec 2018 1:30 pm GNW     Crown Bioscience Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
15 Nov 2018 1:00 pm GNW     Crown Bioscience New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
08 Nov 2018 1:00 pm GNW     Crown Bioscience Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability
06 Nov 2018 1:40 pm GNW     Crown Bioscience Crown Bioscience to Showcase Scientific Expertise at the EORTC-NCI-AACR
25 Oct 2018 2:15 pm GNW     Crown Bioscience CrownBio Releases MuBase® 2.0, An Open Access Database of Immuno-Oncology Murine Models
26 Sep 2018 1:00 pm GNW     Crown Bioscience CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models
18 Sep 2018 1:00 pm GNW     Crown Bioscience CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
13 Sep 2018 1:00 pm GNW     Crown Bioscience CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
14 Aug 2018 1:00 pm GNW     Crown Bioscience CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
27 Jul 2018 9:28 am GNW     Crown Bioscience Inc. CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center
19 Jul 2018 2:03 pm GNW     Crown Bioscience Inc. CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology
19 Jun 2018 1:00 pm GNW     Crown Bioscience Inc. CrownBio Enters Partnership with Pierre Fabre to Accelerate Discovery and Development of Immuno-Oncology Agents
06 Jun 2018 1:00 pm GNW     Crown Bioscience Inc. Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division
09 May 2018 5:05 am GNW     Crown Bioscience Inc. CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting
26 Apr 2018 1:00 pm GNW     Crown Bioscience Inc. CrownBio Launches New Humanized Target Model for Immunotherapy
04 Apr 2018 1:00 pm GNW     Crown Bioscience Inc. CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference
28 Mar 2018 7:00 am GNW     Crown Bioscience Inc. Glycotope Selects CrownBio as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline
22 Mar 2018 1:43 pm GNW     Crown Bioscience Inc. CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
13 Mar 2018 12:00 pm GNW     Crown Bioscience Inc. CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes' Novel Oncology Agents
09 Mar 2018 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies
27 Feb 2018 1:00 pm GNW     Crown Bioscience Inc. Webinar to Reveal Data Supporting the Use of MuScreen(TM) for Preclinical Immunotherapeutic Development
20 Feb 2018 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience Inc.: CAR T-Cell Therapy Platform
09 Feb 2018 1:00 pm GNW     Crown Bioscience Inc. Enhanced MuScreen(TM) Platform Revolutionizes Preclinical Development of Immunotherapeutics
23 Jan 2018 1:53 pm GNW     Crown Bioscience Inc. Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018
17 Jan 2018 1:12 pm GNW     Crown Bioscience Inc. Innovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live Webinar
09 Jan 2018 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience Launches CrownSyn(TM), an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination Studies
21 Dec 2017 4:55 pm GNW     Crown Bioscience Inc. Crown Bioscience Announces Merger with JSR Corporation
20 Dec 2017 2:00 pm GNW     Crown Bioscience Inc. Crown Bioscience International announces Agreement and Plan of Merger with JSR Corporation
07 Dec 2017 3:45 pm GNW     Crown Bioscience Inc. Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology
23 Nov 2017 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring
21 Nov 2017 1:00 pm GNW     Crown Bioscience Inc. CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs
17 Nov 2017 5:07 pm GNW     Crown Bioscience Inc. CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research
09 Nov 2017 10:45 am GNW     Crown Bioscience Inc. Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
19 Oct 2017 1:00 pm GNW     Crown Bioscience Inc. Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience
17 Oct 2017 3:12 pm GNW     Crown Bioscience Inc. Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds
10 Oct 2017 2:45 pm GNW     Crown Bioscience Inc. CrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes
27 Sep 2017 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role
13 Sep 2017 3:28 pm GNW     Crown Bioscience Inc. CrownBio's Integrated Oncology Platform Helps Advance Apogenix's Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer
23 Aug 2017 11:29 am GNW     Crown Bioscience Inc. Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence
14 Aug 2017 5:00 am GNW     Crown Bioscience Inc. Crown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations
01 Aug 2017 1:00 pm GNW     Crown Bioscience Inc. CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research
13 Jul 2017 1:00 pm GNW     Crown Bioscience Inc. Crown Bioscience Expands its Life Science Portfolio
06 Jul 2017 1:00 pm GNW     Crown Bioscience Inc. CrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discovery


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t